Table 1 Demographics and preoperative characteristics of adults who underwent Ross or mAVR Table 1 Demographics and preoperative characteristics of adults who underwent Ross or mAVR Table 1 Demographics and preoperative characteristics of adults who underwent Ross or mAVR Table 1 Demographics and preoperative characteristics of adults who underwent Ross or mAVR Table 1 Demographics and preoperative characteristics of adults who underwent Ross or mAVR
Ross (n = 32) mAVR (n = 32) Total (n = 64)
p value
Age, mean (SD)
36.88 (10.64)
37.38 (9.28) 37.13 (9.91)
0.87
Sex 0.99
Male 22 (68.75) 22 (68.75) 44 (68.75)
Female 10 (31.25) 10 (31.25) 20 (31.25)
Body surface area (m2), mean (SD) 2.06 (0.20) 2.06 (0.35) 2.06 (0.29) 0.60
Cardiovascular risk factors Cardiovascular risk factors Cardiovascular risk factors Cardiovascular risk factors Cardiovascular risk factors
Obesity 3 (9.38) 3 (9.38) 6 (9.38) > 0.99
Smoker 17 (53.13) 17 (53.13) 34 (53.13) > 0.99
Hypertension 16 (50.00) 15 (46.88) 31 (48.44) 0.81
Hyperlipidemia 4 (12.50) 3 (9.38) 7 (10.94) 0.65
Diabetes mellitus 1 (3.13) 1 (3.13) 2 (3.13) > 0.99
Comorbidities Comorbidities Comorbidities Comorbidities Comorbidities
Atrial fibrillation/flutter 6 (18.75) 5 (15.63) 11 (17.19) 0.76
Transient ischemic attack/stroke 3 (9.38) 4 (12.50) 7 (10.94) 0.70
Peripheral vascular disease 1 (3.13) 1 (3.13) 2 (3.13) > 0.99
Chronic obstructive pulmonary disease 1 (3.13) 0 (0.00) 1 (1.56)
Previous cardiac intervention Previous cardiac intervention Previous cardiac intervention Previous cardiac intervention Previous cardiac intervention
Surgical 9 (28.13) 10 (31.25) 19 (29.69) 0.78
Catheter-based 4 (12.50) 1 (3.13) 5 (7.81) 0.35
New York Heart Association functional classification > 0.99
I 7 (21.88) 8 (25.00) 15 (23.44)
II 5 (15.63) 6 (18.75) 11 (17.19)
III 6 (18.75) 3 (9.38) 9 (14.06)
IV 3 (9.38) 2 (6.25) 5 (7.81)
Clinical presentation Clinical presentation Clinical presentation Clinical presentation Clinical presentation
Dyspnea 14 (43.75) 16 (50.00) 30 (46.88) 0.62
Fatigue 11 (34.38) 13 (40.63) 24 (37.50) 0.62
Chest pain/angina 9 (28.13) 10 (31.25) 19 (29.69) 0.74
Palpitations 7 (21.88) 3 (9.38) 10 (15.63) 0.20
Congestive heart failure 4 (12.50) 4 (12.50) 8 (12.50) > 0.99
Presyncope/syncope 3 (9.38) 1 (3.13) 4 (6.25) 0.31
Asymptomatic 6 (18.75) 7 (21.88) 13 (20.31) 0.78
Indication Indication Indication Indication Indication
Aortic stenosis 5 (15.63) 4 (12.50) 9 (14.06) 0.74
Aortic insufficiency 12 (37.50) 20 (62.50) 32 (50.00) 0.05
Mixed 15 (46.88) 6 (18.75) 21 (32.81) 0.02
Bicuspid aortic valve 23 (71.88) 12 (37.50) 35 (54.69) 0.01
Ascending aortic aneurysm 16 (50.00) 6 (18.75) 22 (34.38) 0.02
Endocarditis/rheumatic heart disease 6 (18.75) 10 (31.25) 16 (25.00) 0.28
Variables expressed as number (%) unless otherwise specified. Degree of aortic insufficiency this was collected as none (0), mild (1), moderate (2), severe (3) with the associated numerical values denoted in parentheses. SD, standard deviation. Variables expressed as number (%) unless otherwise specified. Degree of aortic insufficiency this was collected as none (0), mild (1), moderate (2), severe (3) with the associated numerical values denoted in parentheses. SD, standard deviation. Variables expressed as number (%) unless otherwise specified. Degree of aortic insufficiency this was collected as none (0), mild (1), moderate (2), severe (3) with the associated numerical values denoted in parentheses. SD, standard deviation. Variables expressed as number (%) unless otherwise specified. Degree of aortic insufficiency this was collected as none (0), mild (1), moderate (2), severe (3) with the associated numerical values denoted in parentheses. SD, standard deviation. Variables expressed as number (%) unless otherwise specified. Degree of aortic insufficiency this was collected as none (0), mild (1), moderate (2), severe (3) with the associated numerical values denoted in parentheses. SD, standard deviation.